Note: Ingredients listed on restricted chemical lists
EC/CAS
205-500-4/141-78-6
Name of the chemical
acetic acid, ethyl ester
Concentration
100%
General Information
Revision date
2023-03-23
Product name
Ethyl Acetate (C4H8O2)
Substance name
Ethyl Acetate (C4H8O2)
Chemical name
Ethyl Acetate
CAS No.
141-78-6
REACH No
01-2119475103-46-XXXX
1.2.1 Relevant identified uses
Industrial solvent, solvent for coatings, films, perfumes and synthetic flavoring agents, extraction solvent for various products and laboratory procedures
Emergency telephone
+91 7291970499
Icons in SDS
Company Information
company name
Bloomchemag BV
e-mail address of the competent person responsible for the Safety Data Sheet
info@bloomchemag.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H319, H336
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
Highly flammable liquid and vapour. May cause drowsiness or dizziness. Causes serious eye irritation.
2.2 Label elements
Labelling
Hazard pictograms
GHS02 GHS07
Signal word
Danger
Hazard statements
H225 - Highly flammable liquid and vapour. H319 - Causes serious eye irritation. H336 - May cause drowsiness or dizziness.
Precautionary statements
P210 - Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P233 - Keep container tightly closed. P235 - Keep cool. P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P370+P378 - In case of fire: Use media other than water to extinguish. P403+P235 - Store in a well-ventilated place. Keep cool.
Supplemental label elements
EUH066 - Repeated exposure may cause skin dryness or cracking.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605
